What we found
These came out of reading 35 clinics' own pages, and they are why this site exists rather than a directory. Each carries its source and the date we checked it. 6 of the 8 are serious enough that we would want to know before paying.
8 findings
Our link's price is not the public price
CoreAge Rx shows a different price on our link than in public
Our affiliate path showed $79 (per-month) while its public page showed $99 (per-month). We score and publish the PUBLIC figure, and this clinic is held out of any promoted slot for it — the price we show has to be the price a stranger sees.
SourceChecked 2026-09-16Clinic: coreage-rx-glp-1
Third-party record
CoreAge Rx's Trustpilot rating is suspended by Trustpilot
Trustpilot has SUSPENDED this company's rating itself. Banner verbatim: “This company's rating is unavailable due to a breach of our guidelines”, plus “We've removed a number of fake reviews for this company.” Domain confirmed as coreagerx.com before the figure was used.
SourceChecked 2026-08-31Clinic: coreage-rx-glp-1
Two storefronts, one company
Embody and SnagRx are the same company
Both publish the same legal entity — Modern Metabolic Medicine, Inc. — and neither site says they are related. They appear separately in this ranking, so they can look like two independent options when they are one. Compare them knowing that.
Our link's price is not the public price
Embody shows a different price on our link than in public
Our affiliate path showed $69 (per-month) while its public page showed $79 (per-month). We score and publish the PUBLIC figure, and this clinic is held out of any promoted slot for it — the price we show has to be the price a stranger sees.
Regulatory action
FDA warning letter naming Lovely Meds, Inc.
False & Misleading Claims (compounded semaglutide/tirzepatide). Letter 716829, dated 2025-09-09. FDA alleges false claims about compounded semaglutide and tirzepatide. The letter was issued over lovelymeds.com, a DIFFERENT property of the same entity — not over tryageless.com. Lovely Meds, Inc. is the entity named in the footer of the Ageless GLP-1 page our link lands on, which is why it is recorded here. This is an allegation by FDA against the OPERATOR, not an adjudicated finding, and not a letter against this brand's own page. No closeout letter has been posted.
Regulatory action
FDA warning letter naming Strut Health, LLC dba Strut
False & Misleading Claims/Misbranded (Telehealth). Letter 721448, dated 2026-02-20. FDA states it reviewed struthealth.com in December 2025 and observed that the website "offers compounded drug products, including semaglutide and tirzepatide drug products". FDA alleges the website's "false or misleading claims concerning compounded semaglutide and tirzepatide products" render those products misbranded under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. §§ 352(a), 352(bb)], and that introducing them into interstate commerce violates section 301(a) [21 U.S.C. § 331(a)]. This is an allegation by FDA, not an adjudicated finding, and Strut has not been shown to have been found liable by any court. No closeout letter has been posted.
SourceClinic: strut-health
The ongoing rate is not published
SkinnyRx publishes a first-month price and not the one after it
Read the whole product page through a browser — including the subscription, refill and refund sections — and the month-two rate appears nowhere. The only figure published is "$99 first month", under a "while supplies last" banner. So what you pay from month two is unknown before you sign up.
Checked 2026-09-14Clinic: skinnyrx
Third-party record
Strut Health's 3.5 rating rests on old reviews
Only 43 of 777 reviews (6%) are from the last 12 months, so the score describes years-old experience rather than current service.
SourceChecked 2026-08-30Clinic: strut-health
How these are produced
Every finding here is DERIVED from a typed field, never written by hand: the legal entity each brand publishes, the FDA warning-letter record, third-party review records, and the comparison between the price on our affiliate link and the price on the clinic's public page. A finding that cannot be derived does not appear — and a gate fails our build if one exists in the data and renders nowhere. Editorial policy.
An FDA warning letter is an allegation by the agency, not a court ruling, and we say so on each one. Where litigation is contested, we say that too.